» Articles » PMID: 29950010

GSEA-InContext: Identifying Novel and Common Patterns in Expression Experiments

Overview
Journal Bioinformatics
Specialty Biology
Date 2018 Jun 29
PMID 29950010
Citations 135
Authors
Affiliations
Soon will be listed here.
Abstract

Motivation: Gene Set Enrichment Analysis (GSEA) is routinely used to analyze and interpret coordinate pathway-level changes in transcriptomics experiments. For an experiment where less than seven samples per condition are compared, GSEA employs a competitive null hypothesis to test significance. A gene set enrichment score is tested against a null distribution of enrichment scores generated from permuted gene sets, where genes are randomly selected from the input experiment. Looking across a variety of biological conditions, however, genes are not randomly distributed with many showing consistent patterns of up- or down-regulation. As a result, common patterns of positively and negatively enriched gene sets are observed across experiments. Placing a single experiment into the context of a relevant set of background experiments allows us to identify both the common and experiment-specific patterns of gene set enrichment.

Results: We compiled a compendium of 442 small molecule transcriptomic experiments and used GSEA to characterize common patterns of positively and negatively enriched gene sets. To identify experiment-specific gene set enrichment, we developed the GSEA-InContext method that accounts for gene expression patterns within a background set of experiments to identify statistically significantly enriched gene sets. We evaluated GSEA-InContext on experiments using small molecules with known targets to show that it successfully prioritizes gene sets that are specific to each experiment, thus providing valuable insights that complement standard GSEA analysis.

Availability And Implementation: GSEA-InContext implemented in Python, Supplementary results and the background expression compendium are available at: https://github.com/CostelloLab/GSEA-InContext.

Citing Articles

Integrative analysis of m7G methylation-associated genes prognostic signature with immunotherapy and identification of LARP1 as a key oncogene in head and neck squamous cell carcinoma.

Xu J, You Z, Zhu Z, Liu M, Zhang Z, Xu P Front Immunol. 2025; 16:1520070.

PMID: 40018039 PMC: 11864954. DOI: 10.3389/fimmu.2025.1520070.


Coix Seed Oil Alleviates DSS-Induced Ulcerative Colitis via Intestinal Barrier Repair and Ferroptosis Regulation.

Zeng Y, Li N, Deng B, Gu Y, Lu S, Liu Y J Inflamm Res. 2025; 18:2557-2581.

PMID: 39995826 PMC: 11849537. DOI: 10.2147/JIR.S501745.


Disulfidptosis-related gene signatures as prognostic biomarkers and predictors of immunotherapy response in HNSCC.

Qin H, Xu J, Yue Y, Chen M, Zhang Z, Xu P Front Immunol. 2025; 15:1456649.

PMID: 39896807 PMC: 11782277. DOI: 10.3389/fimmu.2024.1456649.


Screening of necroptosis-related genes and evaluating the prognostic capacity, clinical value, and the effect of their copy number variations in acute myeloid leukemia.

Wen D, Yan R, Zhang L, Zhang H, Chen X, Zhou J BMC Cancer. 2025; 25(1):71.

PMID: 39806277 PMC: 11727709. DOI: 10.1186/s12885-025-13439-y.


A comparative analysis of Marburg virus-infected bat and human models from public high-throughput sequencing data.

Xuan D, Yeh I, Liu H, Su C, Ko C, Ta H Int J Med Sci. 2025; 22(1):1-16.

PMID: 39744175 PMC: 11659840. DOI: 10.7150/ijms.100696.


References
1.
Subramanian A, Tamayo P, Mootha V, Mukherjee S, Ebert B, Gillette M . Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005; 102(43):15545-50. PMC: 1239896. DOI: 10.1073/pnas.0506580102. View

2.
Subramanian A, Narayan R, Corsello S, Peck D, Natoli T, Lu X . A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles. Cell. 2017; 171(6):1437-1452.e17. PMC: 5990023. DOI: 10.1016/j.cell.2017.10.049. View

3.
Goeman J, Buhlmann P . Analyzing gene expression data in terms of gene sets: methodological issues. Bioinformatics. 2007; 23(8):980-7. DOI: 10.1093/bioinformatics/btm051. View

4.
Shoemaker R . The NCI60 human tumour cell line anticancer drug screen. Nat Rev Cancer. 2006; 6(10):813-23. DOI: 10.1038/nrc1951. View

5.
Chen L, Fink T, Ebbesen P, Zachar V . Temporal transcriptome of mouse ATDC5 chondroprogenitors differentiating under hypoxic conditions. Exp Cell Res. 2006; 312(10):1727-44. DOI: 10.1016/j.yexcr.2006.02.013. View